ImmunologyAdvanced SciencePeer-reviewed
Dual blockade of LILRB1 and LILRB2 enhances antiviral immune responses in SIV infection
Florian Meurisse, Sixtine Coindre, Anne Wijkhuisen…·Benoı̂t Favier
This study shows that blocking LILRB1 and LILRB2 with a dual-specific antibody enhances antiviral immune responses in SIV infection without adverse effects.
DOI 10.1002/advs.76557